BCAL Diagnostics
A$0.065000
1
-A$0.00-2.99% Tuesday 05:35
Statistics
Day High
0.067
Day Low
0.065
52W High
0.155
52W Low
0.052
Volume
203,109
Avg. Volume
362,087
Mkt Cap
23.92M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
28AugExpected
Q4 2023
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.01
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
0Net Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Show more...
CEO
Anne-Louise Arnett
Employees
6
Country
Australia
ISIN
AU0000160921
Listings
0 Comments
Share your thoughts
FAQ
What is BCAL Diagnostics stock price today?▼
The current price of BDX.AU is A$0.07 AUD — it has decreased by -2.99% in the past 24 hours. Watch BCAL Diagnostics stock price performance more closely on the chart.
What is BCAL Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange BCAL Diagnostics stocks are traded under the ticker BDX.AU.
Is BCAL Diagnostics stock price growing?▼
BDX.AU stock has fallen by -4.41% compared to the previous week, the month change is a +0% rise, over the last year BCAL Diagnostics has showed a +6.56% increase.
What is BCAL Diagnostics market cap?▼
Today BCAL Diagnostics has the market capitalization of 23.92M
When is the next BCAL Diagnostics earnings date?▼
BCAL Diagnostics is going to release the next earnings report on February 23, 2027.
What is BCAL Diagnostics revenue for the last year?▼
BCAL Diagnostics revenue for the last year amounts to 0 AUD.
What is BCAL Diagnostics net income for the last year?▼
BDX.AU net income for the last year is 0 AUD.
How many employees does BCAL Diagnostics have?▼
As of September 09, 2026, the company has 6 employees.
In which sector is BCAL Diagnostics located?▼
BCAL Diagnostics operates in the Health & Wellness sector.
When did BCAL Diagnostics complete a stock split?▼
BCAL Diagnostics has not had any recent stock splits.
Where is BCAL Diagnostics headquartered?▼
BCAL Diagnostics is headquartered in Sydney, Australia.